<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><description>It takes nothing to join the crowd, but it takes everything to stand alone</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 10 Feb 2021 07:59:44 +0800</pubDate><image><url>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</url><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>药物从研发到上市过程</title><link>https://mp.weixin.qq.com/s/t2jxmvkSOu0jnGpGedOH_w</link><description></description><content:encoded><![CDATA[药物从研发到上市过程]]></content:encoded><pubDate>Tue, 09 Feb 2021 19:07:13 +0800</pubDate></item><item><title>他来了他来了！NMPA发布寒假作业！一大批指导原则发布！</title><link>https://mp.weixin.qq.com/s/u9ojA9TRODp1sqaYsClZzw</link><description></description><content:encoded><![CDATA[他来了他来了！NMPA发布寒假作业！一大批指导原则发布！]]></content:encoded><pubDate>Tue, 09 Feb 2021 19:07:13 +0800</pubDate></item><item><title>注射剂一致性评价：CDE老师带你梳理全流程的药学要求！</title><link>https://mp.weixin.qq.com/s/fjfygXsCb4o9JsJ2vD8I1A</link><description></description><content:encoded><![CDATA[注射剂一致性评价：CDE老师带你梳理全流程的药学要求！]]></content:encoded><pubDate>Tue, 09 Feb 2021 19:07:13 +0800</pubDate></item><item><title>全文版 | CDE发布《模型引导的药物研发技术指导原则》</title><link>https://mp.weixin.qq.com/s/-_zov99hQgR0fY2Vk9sjzQ</link><description></description><content:encoded><![CDATA[全文版 | CDE发布《模型引导的药物研发技术指导原则》]]></content:encoded><pubDate>Tue, 09 Feb 2021 19:07:13 +0800</pubDate></item><item><title>一文看懂全球获批的四款CAR-T疗法</title><link>https://mp.weixin.qq.com/s/CUGyerRlKpDxOLu3O1m10g</link><description></description><content:encoded><![CDATA[一文看懂全球获批的四款CAR-T疗法]]></content:encoded><pubDate>Mon, 08 Feb 2021 18:52:00 +0800</pubDate></item><item><title>CDE丨发布《治疗性蛋白药物临床药代动力学研究技术指导原则》</title><link>https://mp.weixin.qq.com/s/2Wa-HXq_I16SrvY9YZOmTA</link><description></description><content:encoded><![CDATA[CDE丨发布《治疗性蛋白药物临床药代动力学研究技术指导原则》]]></content:encoded><pubDate>Mon, 08 Feb 2021 18:52:00 +0800</pubDate></item><item><title>CDE对制剂工艺中过量灌装与过量投料的审评尺度</title><link>https://mp.weixin.qq.com/s/7ga6XSisc1stqDsCcF3A_Q</link><description></description><content:encoded><![CDATA[CDE对制剂工艺中过量灌装与过量投料的审评尺度]]></content:encoded><pubDate>Mon, 08 Feb 2021 18:52:00 +0800</pubDate></item><item><title>【干货分享】药品注册管理办法48个热点问题答疑</title><link>https://mp.weixin.qq.com/s/W9j5B5HM80oOONBf23Ftpw</link><description></description><content:encoded><![CDATA[【干货分享】药品注册管理办法48个热点问题答疑]]></content:encoded><pubDate>Sun, 07 Feb 2021 19:17:26 +0800</pubDate></item><item><title>2021年度药品注册申请现场核查培训学习整理</title><link>https://mp.weixin.qq.com/s/A5mJrLTSMdr0hwBu0T6S-A</link><description></description><content:encoded><![CDATA[2021年度药品注册申请现场核查培训学习整理]]></content:encoded><pubDate>Sun, 07 Feb 2021 19:17:26 +0800</pubDate></item><item><title>多肽药物研发趋势</title><link>https://mp.weixin.qq.com/s/XNLE6s_tD08HfrOg8OIr-Q</link><description></description><content:encoded><![CDATA[多肽药物研发趋势]]></content:encoded><pubDate>Sun, 07 Feb 2021 19:17:26 +0800</pubDate></item><item><title>《2020年度医疗器械注册工作报告》发布，26个创新产品获批上市！（附图解）</title><link>https://mp.weixin.qq.com/s/5Lk5VenecqQ_L5on98mh8w</link><description></description><content:encoded><![CDATA[《2020年度医疗器械注册工作报告》发布，26个创新产品获批上市！（附图解）]]></content:encoded><pubDate>Sat, 06 Feb 2021 20:48:53 +0800</pubDate></item><item><title>重磅！《药用玻璃容器分类与应用指南（征求意见稿）》发布</title><link>https://mp.weixin.qq.com/s/lKBK_thA301z1Rq14elteQ</link><description></description><content:encoded><![CDATA[重磅！《药用玻璃容器分类与应用指南（征求意见稿）》发布]]></content:encoded><pubDate>Sat, 06 Feb 2021 20:48:53 +0800</pubDate></item><item><title>第四款CAR-T获得FDA批准上市！BMS重金收购而来的CAR-T细胞产品终于成功上市！丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/2HXIm3g8jpgnYs-PLPlU7g</link><description></description><content:encoded><![CDATA[第四款CAR-T获得FDA批准上市！BMS重金收购而来的CAR-T细胞产品终于成功上市！丨医麦猛爆料]]></content:encoded><pubDate>Sat, 06 Feb 2021 20:48:53 +0800</pubDate></item><item><title>国内第2款！北京科兴中维生物新冠疫苗获国家药监局附条件批准上市！</title><link>https://mp.weixin.qq.com/s/E3VMtO63gqWmTuhwpF-mtA</link><description></description><content:encoded><![CDATA[国内第2款！北京科兴中维生物新冠疫苗获国家药监局附条件批准上市！]]></content:encoded><pubDate>Sat, 06 Feb 2021 20:48:53 +0800</pubDate></item><item><title>CDE｜发布《注射用奥马珠单抗生物类似药临床试验指导原则》的通告（2021年第8号）</title><link>https://mp.weixin.qq.com/s/X0NyWfDzQMM4pcGo6ClLlw</link><description></description><content:encoded><![CDATA[CDE｜发布《注射用奥马珠单抗生物类似药临床试验指导原则》的通告（2021年第8号）]]></content:encoded><pubDate>Thu, 04 Feb 2021 22:22:44 +0800</pubDate></item><item><title>创新医疗器械申报须知</title><link>https://mp.weixin.qq.com/s/yXTZDnawM7tmg2E9tn9n_g</link><description></description><content:encoded><![CDATA[创新医疗器械申报须知]]></content:encoded><pubDate>Thu, 04 Feb 2021 22:22:44 +0800</pubDate></item><item><title>生理药动学模型在固体口服制剂一致性评价中的应用</title><link>https://mp.weixin.qq.com/s/OgFXK5iH0r2VsCyHal-2jw</link><description></description><content:encoded><![CDATA[生理药动学模型在固体口服制剂一致性评价中的应用]]></content:encoded><pubDate>Wed, 03 Feb 2021 19:56:27 +0800</pubDate></item><item><title>重磅！NMPA发布2021年监管计划</title><link>https://mp.weixin.qq.com/s/lnAKhxCiCy7KmXugCb8zVQ</link><description></description><content:encoded><![CDATA[重磅！NMPA发布2021年监管计划]]></content:encoded><pubDate>Wed, 03 Feb 2021 19:56:27 +0800</pubDate></item><item><title>ICHQ8（R2） 药品研发ppt</title><link>https://mp.weixin.qq.com/s/B_RHWDsg-S9vdK9aysfFkg</link><description></description><content:encoded><![CDATA[ICHQ8（R2） 药品研发ppt]]></content:encoded><pubDate>Wed, 03 Feb 2021 19:56:27 +0800</pubDate></item><item><title>单抗结构和基础知识</title><link>https://mp.weixin.qq.com/s/bcDLQqLjWkYueHDMeeikFw</link><description></description><content:encoded><![CDATA[单抗结构和基础知识]]></content:encoded><pubDate>Tue, 02 Feb 2021 19:12:17 +0800</pubDate></item></channel></rss>